Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Mania and Antimanic Drugs: Overview01:24

Mania and Antimanic Drugs: Overview

483
Mania, a psychological condition characterized by elevated mood, increased energy, and reduced sleep need, is part of the bipolar disorder cycle. The exact cause of mania isn't entirely known, but it is thought to be a combination of genetic, environmental, and neurological factors. Bipolar disorder involves alternating manic and depressive episodes. Mood stabilizers like lithium, antipsychotics, and anticonvulsants help manage these episodes. Lithium carbonate is particularly effective as...
483
Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers01:22

Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers

2.5K
Class I antiarrhythmic drugs are used to treat various types of arrhythmias or irregular heart rhythms. These drugs block the sodium (Na+) channels in the cardiac cells, thereby affecting the movement of electrical impulses across the heart. Class I antiarrhythmic drugs are divided into three subgroups: Class IA, Class IB, and Class IC, each with distinct mechanisms of action and effects on the heart.
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
2.5K
Drug Accumulation During Multiple Dosing: Intermittent IV Infusions01:24

Drug Accumulation During Multiple Dosing: Intermittent IV Infusions

153
Intermittent intravenous (IV) infusion is a method of drug administration where medications are delivered over short infusion periods followed by intervals of no drug delivery. This approach helps to prevent sustained high drug concentrations in the bloodstream, reducing the risk of adverse effects associated with prolonged exposure. Unlike continuous infusion, steady-state concentrations may not be achieved during a single dosing cycle but can be reached through repeated...
153
Determination of Multiple Dosing Parameters: Loading and Maintenance Doses01:25

Determination of Multiple Dosing Parameters: Loading and Maintenance Doses

130
A loading dose is an essential pharmacological strategy to rapidly achieve the target plasma drug concentration necessary for an immediate therapeutic effect. This approach is especially critical for drugs characterized by slow absorption or extended half-lives, where delaying therapeutic plasma levels could compromise treatment outcomes. By administering a loading dose, clinicians ensure a prompt onset of drug action, even for agents with complex pharmacokinetic profiles.Achieving steady-state...
130
Rational Dosage Regimen: Maintenance Dose and Loading Dose01:24

Rational Dosage Regimen: Maintenance Dose and Loading Dose

5.0K
A rational dosage regimen considers a drug's pharmacokinetics, including its absorption, distribution, metabolism, and elimination from the body. By understanding these factors, the appropriate dosage can be determined, and the dosing schedule can be designed to achieve and maintain the desired therapeutic effect while minimizing adverse effects.
In most cases, drugs are administered repetitively or infused continuously to maintain a steady-state concentration in the body. At a steady...
5.0K
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

147
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
147

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Antidepressant Remission and Manic Switch in Bipolar Depression: A Propensity Score Analysis.

Acta psychiatrica Scandinavica·2025
Same author

Conspiratorial thinking in a 50-state survey of American adults.

medRxiv : the preprint server for health sciences·2024
Same author

The pseudoscience of lithium and suicide: Reanalysis of a misleading meta-analysis.

Journal of psychopharmacology (Oxford, England)·2024
Same author

COVID-19 Impact on the Italian Community-based System of Mental Health Care: Reflections and Lessons Learned for the Future.

Clinical psychopharmacology and neuroscience : the official scientific journal of the Korean College of Neuropsychopharmacology·2023
Same author

Drug Discovery in Psychiatry: Rethinking Conventional Wisdom.

Canadian journal of psychiatry. Revue canadienne de psychiatrie·2022
Same author

Symptomatic versus disease-modifying effects of psychiatric drugs.

Acta psychiatrica Scandinavica·2022
Same journal

Developmental Trauma as a Prognostic Factor for Later Psychotic Disorder in an Adolescent Clinical Cohort: A 20-Year Follow Up Study.

Acta psychiatrica Scandinavica·2026
Same journal

The Prevalence of Obstructive Sleep Apnoea in Schizophrenia, Bipolar Disorder and Major Depressive Disorder: A Systematic Review With Meta-Analysis.

Acta psychiatrica Scandinavica·2026
Same journal

Use of Glucagon-Like Peptide 1 Receptor Agonists and the Associated Risk of Hospitalisation in Bipolar Disorder, From a Nationwide Cohort, 2009-2024.

Acta psychiatrica Scandinavica·2026
Same journal

Benzodiazepine Use and Mortality Risk: A Nationwide Cohort Study on New Benzodiazepine Users With a 5-Year Follow-Up.

Acta psychiatrica Scandinavica·2026
Same journal

Leveraging Family Genetic Risk Scores to Understand the Etiology of Suicidal Behaviors and Their Associations With Psychiatric Disorders.

Acta psychiatrica Scandinavica·2026
Same journal

Does the Loss of Autobiographical Memories Contribute to the Therapeutic Effect of Electroconvulsive Therapy?

Acta psychiatrica Scandinavica·2026
See all related articles

Related Experiment Video

Updated: Dec 18, 2025

In Situ Neutron Powder Diffraction Using Custom-made Lithium-ion Batteries
11:25

In Situ Neutron Powder Diffraction Using Custom-made Lithium-ion Batteries

Published on: November 10, 2014

16.2K

When and how to use lithium.

S A Barroilhet1,2, S N Ghaemi2,3

  • 1Psychiatry, Faculty of Medicine, University Psychiatric Clinic, University of Chile, Santiago, Chile.

Acta Psychiatrica Scandinavica
|June 12, 2020
PubMed
Summary
This summary is machine-generated.

Lithium is a highly effective psychiatric medication with disease-modifying effects beyond symptom relief. This review highlights its benefits in bipolar disorder, depression, suicide prevention, and potential dementia prevention, advocating for judicious low-dose use.

Keywords:
bipolar illnessdementiadepressiondosinglithiumside effectssuicide

More Related Videos

In Situ Lithiated Reference Electrode: Four Electrode Design for In-operando Impedance Spectroscopy
09:36

In Situ Lithiated Reference Electrode: Four Electrode Design for In-operando Impedance Spectroscopy

Published on: September 12, 2018

9.1K
A Protocol for Safe Lithiation Reactions Using Organolithium Reagents
09:45

A Protocol for Safe Lithiation Reactions Using Organolithium Reagents

Published on: November 12, 2016

31.8K

Related Experiment Videos

Last Updated: Dec 18, 2025

In Situ Neutron Powder Diffraction Using Custom-made Lithium-ion Batteries
11:25

In Situ Neutron Powder Diffraction Using Custom-made Lithium-ion Batteries

Published on: November 10, 2014

16.2K
In Situ Lithiated Reference Electrode: Four Electrode Design for In-operando Impedance Spectroscopy
09:36

In Situ Lithiated Reference Electrode: Four Electrode Design for In-operando Impedance Spectroscopy

Published on: September 12, 2018

9.1K
A Protocol for Safe Lithiation Reactions Using Organolithium Reagents
09:45

A Protocol for Safe Lithiation Reactions Using Organolithium Reagents

Published on: November 12, 2016

31.8K

Area of Science:

  • Psychiatry
  • Neurobiology
  • Pharmacology

Background:

  • Lithium is an established psychiatric medication that is underutilized in contemporary clinical practice.
  • Evidence for lithium's benefits and risks requires re-examination to guide its appropriate use.
  • Understanding lithium's therapeutic profile is crucial for optimizing patient outcomes.

Purpose of the Study:

  • To review the evidence supporting the benefits and risks associated with lithium therapy.
  • To provide clinical guidance for the effective and safe use of lithium.
  • To re-evaluate lithium's role in managing various psychiatric conditions.

Main Methods:

  • This study employed a narrative review methodology.
  • Evidence from existing literature was synthesized to assess lithium's efficacy and safety.
  • Clinical guidance was formulated based on the reviewed evidence.

Main Results:

  • Lithium demonstrates significant benefits beyond bipolar disorder, including prevention of unipolar depression and suicide.
  • Emerging research suggests neurobiological advantages for cognition and potential dementia prevention.
  • Low-dose lithium (under 1.0 mmol/L) is recommended to minimize side effects and toxicity, while high doses should be avoided.
  • Strategies for managing lithium's side effects are available to improve patient adherence.

Conclusions:

  • Lithium is a disease-modifying agent, not merely symptomatic, making it a highly effective psychiatric treatment.
  • Its efficacy extends to bipolar disorder, suicide prevention, unipolar depression, mood disorders, and potentially dementia.
  • Increased appreciation of lithium's benefits, coupled with optimized low-dose regimens, can enhance its therapeutic value and safety profile.